PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | |rheumatoid arthritis |
| Sentences | 72 |
| PubMedID- 21180241 | Platelet histogram indices and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 22521305 | Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 20868308 | Objectives: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd). |
| PubMedID- 26180748 | The association of rheumatoid arthritis (ra) with increased vascular disease is well established (kitas et al. |
| PubMedID- 25969671 | Several epidemiological studies reported increased morbidity and mortality from cardiovascular diseases in patients with rheumatoid arthritis [2], and strong evidences from basic research and epidemiological studies support that inflammation and venous thrombosis are associated processes [3]. |
| PubMedID- 26362702 | [risk factors for cardiovascular disease in rheumatoid arthritis patients from mato grosso do sul]. |
| PubMedID- 26023546 | Evaluation of serum magnesium, lipid profile and various biochemical parameters as risk factors of cardiovascular diseases in patients with rheumatoid arthritis. |
| PubMedID- 24361194 | Usefulness of the ankle-brachial index as a survey method for subclinical vascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21071477 | Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. |
| PubMedID- 24585741 | Objective: despite numerous studies reporting increased cardiovascular disease (cvd) in patients with rheumatoid arthritis (ra), the impact of ra on managing modifiable cvd risk factors remains understudied. |
| PubMedID- 20827876 | Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions. |
| PubMedID- 21385539 | Lack of association between lep rs2167270 (19 g>a) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 22935383 | Objectives: the impact of metabolic risk factors on atherosclerotic cardiovascular disease (acvd) in patients with rheumatoid arthritis (ra) from developing populations is currently unknown. |
| PubMedID- 22337246 | Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 22284683 | We also suggest strategies for risk stratification and treatment of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 24511540 | For instance, angiopoietin-2 (angpt-2), a marker of endothelial cell activation, has been proposed as a mediator of angiogenesis, which might play an important role in the regulation of endothelial integrity and inflammation and thus is related to severity and cardiovascular disease in patients with rheumatoid arthritis [2]. |
| PubMedID- 21411091 | Prediction of genetic risk for cardiovascular disease in patients with rheumatoid arthritis: present and promises. |
| PubMedID- 21608334 | Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis. |
| PubMedID- 22360682 | Lack of association between tlr4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 23666917 | Objective: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd), but little is known about its association with another form of vascular disorder, venous thromboembolism (vte). |
| PubMedID- 25011482 | Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21269581 | Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 22337612 | Apolipoprotein b-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 24498229 | In observational studies the finding of incident cardiovascular disease in patients with rheumatoid arthritis exposed to glucocorticoids is strongly confounded by indication due to high disease activity. |
| PubMedID- 20040642 | Risk factors for cardiovascular disease in rheumatoid arthritis: defining treatment thresholds. |
| PubMedID- 21073447 | Lack of association between adipoq rs266729 and adipoq rs1501299 polymorphisms and cardiovascular disease in rheumatoid arthritis patients. |
| PubMedID- 23300117 | Objectives: to assess the effect of golimumab, with or without methotrexate (mtx), on serum lipids and inflammatory markers of cardiovascular disease (cvd) in patients with rheumatoid arthritis (ra) in two phase 3, randomised, placebo-controlled trials (go-before and go-forward). |
| PubMedID- 21276397 | [excess mortality from cardiovascular disease in patients with rheumatoid arthritis]. |
| PubMedID- 23256829 | The risk of cardiovascular disease associated with rheumatoid arthritis equals that of diabetes mellitus. |
| PubMedID- 21981268 | Lack of association of il6r rs2228145 and il6st/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 23848174 | Cardiovascular diseases in patients with rheumatoid arthritis: comment on the article by koivuniemi et al. |
| PubMedID- 23983474 | The effects of the il-6r and il-6st/gp130 genes on the risk for cardiovascular disease in patients with rheumatoid arthritis were assessed in patients with rheumatoid arthritis who were genotyped for the functional gene polymorphisms. |
| PubMedID- 25026799 | [cardiovascular diseases in patients with rheumatoid arthritis during long-term methotrexate therapy]. |
| PubMedID- 20842919 | [cardiovascular diseases in rheumatoid arthritis]. |
| PubMedID- 22272574 | Influence of mhciita rs3087456 and rs4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis. |
| PubMedID- 23899926 | Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 23204310 | Atherosclerosis and cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 24874661 | Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis. |
| PubMedID- 23244227 | Cardiovascular diseases in patients with rheumatoid arthritis. |
| PubMedID- 20952464 | Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. |
| PubMedID- 21420089 | Tnfa -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 23749610 | Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study. |
| PubMedID- 24795506 | Lack of association between abo, ppap2b, adamst7, pik3cg, and ednra and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21520672 | [excess mortality from cardiovascular disease in patients with rheumatoid arthritis--nsaid a possible cause. |
| PubMedID- 25754335 | rheumatoid arthritis (ra) associates with increased cardiovascular disease (cvd) mortality thought to be due to accelerated arterial disease. |
| PubMedID- 23166616 | Also, although in some studies there was a synergist effect of smoking and genetic factors on the increased risk of cardiovascular disease of patients with rheumatoid arthritis, in our population we found no additive effect of smoking and cd40-cd154 gene polymorphisms (data not shown). |
| PubMedID- 24458537 | The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients. |
| PubMedID- PMC3518263 | Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. |
| PubMedID- 26117596 | Prevention of cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 20735865 | Palomino-morales and colleagues [1] report the novel observation that a common polymorphism in the gene for methylene tetrahydrofolate reductase (mthfr) that markedly reduces enzyme activity (by as much as 65% in homozygotes) may predispose to the development of atherosclerotic cardiovascular disease (ascvd) in patients with rheumatoid arthritis (ra). |
Page: 1 2